Clinical Trial Update: Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Macugen (pegaptanib) for macular edema due to Branch Retinal Vein Occlusion has completed and results were posted on 2014-09-12.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Macugen (pegaptanib sodium)

Snippet

Sponsor: Palmetto Retina Center, LLC | Conditions: Branch Retinal Vein Occlusion | Phase 4 | Status: COMPLETED | Results posted: 2014-09-12